Integrin alpha-1 (ITGA1 or CD49a) Antibody - FFPE Validated

About the Target

This antibody is suited for researchers who want to analyze Integrin alpha-1 (ITGA1) and relate it to cell-state biology. Integrin alpha-1 is an extracellular or receptor-linked component that coordinates matrix engagement with cytoskeletal remodeling. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol ITGA1.

Research Context

Comparative experiments can separate expression differences from changes in adhesion structure abundance. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Consider these angles when interpreting target-level changes:

• effects of adhesion inhibitors or matrix composition
• co-variation with cytoskeletal and scaffold partners
• focal adhesion versus diffuse membrane distribution

Variant Considerations

In sectioned tissue workflows, interpretation often depends on morphology; this format supports that style of readout. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

When interpreting Integrin alpha-1, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Integrin alpha-1 patterns can be compared across experiments without guesswork.

As you refine hypotheses around Integrin alpha-1 (ITGA1), the fixed-section format helps keep conclusions tied to preparation context.